Read what the annual report
actually buries.
Six forensic engines, run across the NSE and BSE universe. The auditor’s CARO annexure, related-party schedules, contingent-liability footnotes, board composition, earnings quality — sourced page-by-page from the company’s own filings. Not recommendations. Research and analytical synthesis built for your own thinking.
Every clause from the auditor's CARO 2020 annexure parsed, ranked by severity, mapped to the filing page.
Every disclosed related-party deal — director pay, group lending, subsidiary purchases — surfaced with counterparty and value.
Off-balance-sheet exposures, guarantees, pending litigation — versus net worth, with trend over 5 years.
Director independence, chair-CEO separation, statutory auditor tenure, board remuneration as % of net profit.
Cash-flow-to-profit matching, accrual quality, working-capital absorption — a single 0–100 composite score.
Altman Z, Piotroski F, Beneish M, and the composite risk score — the spreadsheet sweep no retail report shows.
Sourced from the filings. Not opinions.
Every flag we surface points to a specific page in a specific filing — the auditor’s annexure clause, the related-party schedule line, the contingent-liability footnote. Click any badge, jump to the source. We do not synthesise from news, broker reports, or sentiment. Only the filings.
ROE decomposition — operating vs financing leverage, sustainable growth rate.
Distance-to-default — how many sigmas of asset-value drop until insolvency.
Market-implied growth — what FCF growth the current price requires.
Residual income — accounting-anchored valuation, no DCF gymnastics.
Where every rupee of OCF went — capex, dividends, debt, retained — and whether it compounded.
What does Bharat Equity actually do?
We read the annual reports across the NSE and BSE universe and surface the bits retail investors don't read — the auditor's CARO annexure, related-party schedules, contingent-liability footnotes, board composition, audit-firm rotation, and earnings-quality signals. The output is a six-engine forensic dossier per stock, sourced page-by-page from the filing.
Do you give buy / sell / hold calls?
No. We are a research library, not an advisor. Every flag on the platform is descriptive analysis of public filings — built for your own thinking, not as a recommendation to buy, sell, or hold any security.
How is this different from Screener.in or Trendlyne?
Those are quote- and ratio-driven tools. Bharat Equity reads the prose of the filing — the auditor's notes, the related-party schedule, the contingent-liability footnotes — and turns the qualitative disclosures into machine-readable flags. The screener is one tab; the forensic engines are the product.
What does the ₹999 plan include?
Everything: all six forensic engines on every listing in your set, all five academic lenses (Penman ROE decomposition, Merton distance-to-default, Mauboussin implied growth, Ohlson residual income, Buffett capital allocation), the screener, peer compare, sector heat-map, watchlist + alerts, and a fresh AI-synthesised deep-dive on four stocks per month from a 5,000-name universe.
Is there a free way to try it?
Yes — every visitor can open the full six-engine forensic dossier on Dixon Technologies (DIXON.NS) without signing in. It is the single open showcase, designed to be representative of what a Pro subscriber sees on every other listing.
The full forensic stack runs on Dixon, no sign-in.
A research library, not an advisor. Everything you read on Bharat Equity is descriptive analysis of public filings — built for your own thinking, not as a recommendation to buy, sell, or hold any security. Past performance does not predict future results.